• Treffer 1 von 1
Zurück zur Trefferliste

Revisiting adult neurogenesis and the role of erythropoietin for neuronal and oligodendroglial differentiation in the hippocampus

Zitieren Sie bitte immer diese URN: urn:nbn:de:bvb:20-opus-186669
  • Recombinant human erythropoietin (EPO) improves cognitive performance in neuropsychiatric diseases ranging from schizophrenia and multiple sclerosis to major depression and bipolar disease. This consistent EPO effect on cognition is independent of its role in hematopoiesis. The cellular mechanisms of action in brain, however, have remained unclear. Here we studied healthy young mice and observed that 3-week EPO administration was associated with an increased number of pyramidal neurons and oligodendrocytes in the hippocampus of similar to 20%.Recombinant human erythropoietin (EPO) improves cognitive performance in neuropsychiatric diseases ranging from schizophrenia and multiple sclerosis to major depression and bipolar disease. This consistent EPO effect on cognition is independent of its role in hematopoiesis. The cellular mechanisms of action in brain, however, have remained unclear. Here we studied healthy young mice and observed that 3-week EPO administration was associated with an increased number of pyramidal neurons and oligodendrocytes in the hippocampus of similar to 20%. Under constant cognitive challenge, neuron numbers remained elevated until >6 months of age. Surprisingly, this increase occurred in absence of altered cell proliferation or apoptosis. After feeding a \(^{15}\)N-leucine diet, we used nanoscopic secondary ion mass spectrometry, and found that in EPO-treated mice, an equivalent number of neurons was defined by elevated \(^{15}\)N-leucine incorporation. In EPO-treated NG2-Cre-ERT2 mice, we confirmed enhanced differentiation of preexisting oligodendrocyte precursors in the absence of elevated DNA synthesis. A corresponding analysis of the neuronal lineage awaits the identification of suitable neuronal markers. In cultured neurospheres, EPO reduced Sox9 and stimulated miR124, associated with advanced neuronal differentiation. We are discussing a resulting working model in which EPO drives the differentiation of non-dividing precursors in both (NG2+) oligodendroglial and neuronal lineages. As endogenous EPO expression is induced by brain injury, such a mechanism of adult neurogenesis may be relevant for central nervous system regeneration.zeige mehrzeige weniger

Volltext Dateien herunterladen

Metadaten exportieren

Weitere Dienste

Teilen auf Twitter Suche bei Google Scholar Statistik - Anzahl der Zugriffe auf das Dokument
Metadaten
Autor(en): I. Hassouna, C. Ott, L. Wüstefeld, N. Offen, R. A. Neher, M. Mitkovski, D. Winkler, S. Sperling, L. Fries, S. Goebbels, I. C. Vreja, N. Hagemeyer, M. Dittrich, M. F. Rossetti, K. Kröhnert, K. Hannke, S. Boretius, A. Zeug, C. Höschen, T. Dandekar, E. Dere, E. Neher, S. O. Rizzoli, K.-A. Nave, A.-L. Sirén, H. Ehrenreich
URN:urn:nbn:de:bvb:20-opus-186669
Dokumentart:Artikel / Aufsatz in einer Zeitschrift
Institute der Universität:Medizinische Fakultät / Neurochirurgische Klinik und Poliklinik
Fakultät für Biologie / Theodor-Boveri-Institut für Biowissenschaften
Sprache der Veröffentlichung:Englisch
Titel des übergeordneten Werkes / der Zeitschrift (Englisch):Molecular Psychiatry
Erscheinungsjahr:2016
Band / Jahrgang:21
Heft / Ausgabe:12
Seitenangabe:1752-1767
Originalveröffentlichung / Quelle:Molecular Psychiatry (2016) 21:12, 1752-1767. https://doi.org/10.1038/mp.2015.212
DOI:https://doi.org/10.1038/mp.2015.212
Allgemeine fachliche Zuordnung (DDC-Klassifikation):5 Naturwissenschaften und Mathematik / 57 Biowissenschaften; Biologie / 570 Biowissenschaften; Biologie
6 Technik, Medizin, angewandte Wissenschaften / 61 Medizin und Gesundheit / 610 Medizin und Gesundheit
Freie Schlagwort(e):brain-injury; cognitive functions; memory; mice; mouse-brain; nervous-sytem; neural stem-cells; progenitors; pyramidal neurons; recombinat-human-erythropoietin
Datum der Freischaltung:27.05.2020
Lizenz (Deutsch):License LogoCC BY-NC-ND: Creative-Commons-Lizenz: Namensnennung, Nicht kommerziell, Keine Bearbeitungen 4.0 International